Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroMass is a full-service healthcare communications agency that specializes in applying behavioral science to improve patient outcomes and brand performance. The company develops evidence-based strategies and creative solutions designed to change the behavior of patients and healthcare providers. By leveraging a proprietary behavioral science framework, MicroMass creates personalized experiences across various therapeutic areas, including oncology, rare disease, and chronic conditions. Their services include patient support programs, HCP engagement, and digital health solutions tailored to the specific needs of the life sciences industry. Since its acquisition, it operates as part of the Inizio network, providing specialized marketing and patient engagement services to global pharmaceutical and biotech clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroMass Communications.